Blue Jet Healthcare Launches Major Project

The new greenfield facility is being constructed on a 102-acre site in the Rambilli Industrial Park, a designated Special Economic Zone in Andhra Pradesh. This location is part of a broader state-led initiative to create robust, cluster-based industrial development, with a specific focus on making the region a major hub for pharmaceuticals and petrochemicals. The plant will manufacture Active Pharmaceutical Ingredients (APIs) and specialty intermediates, with a planned production capacity of approximately 2,000 kilolitres. Key products will include contrast media intermediates, used in medical imaging, and high-intensity sweeteners. This aligns with Blue Jet's established role as a key global supplier of contrast media ingredients. Development of the facility will occur in phases, with the plant targeted to be fully operational by the 2028-29 fiscal year. The project is expected to create 1,750 direct and 250 indirect employment opportunities, significantly impacting the Visakhapatnam economic region. Founded in 1968 as Jet Chemicals, the Maharashtra-headquartered Blue Jet Healthcare has grown into an integrated Contract Development and Manufacturing Organisation (CDMO). It supplies advanced pharmaceutical ingredients to regulated markets in Europe and the United States, positioning itself as a strategic supplier to multinational pharmaceutical companies. A significant feature of the new plant is its focus on environmental sustainability, incorporating advanced Zero Liquid Discharge (ZLD) technology. This system is designed to recover 90-95% of wastewater and reduce energy consumption by nearly 70%, meeting increasingly stringent ESG (Environmental, Social, and Governance) compliance standards in the global pharma supply chain.